References
- Beduleva, L., Khramova, T., Menshikov, I., Stolyarova, E., & Pavlova, S. (2016). Combined action of anti-CD4 autoantibodies and rheumatoid factor in the development of CD4 lymphocytopenia in rats immunized with HIV-1 gp120. AIDS Research and Human Retroviruses, 32(12), 1173–1179. https://doi.org/10.1089/aid.2015.0358
- Beduleva, L., Khramova, T., Sidorov, A., Terentiev, A., Abisheva, N., Menshikova, D., Ivanov, P., Fomina, K., Gorbushina, A., Shklyaeva, N., & Menshikov, I. (2021). Suppression of experimental autoimmune encephalomyelitis by IgG Fc fragments bearing regRF epitopes. International Immunopharmacology, 101(PtA), 108309. https://doi.org/10.1016/j.intimp.2021.108309
- Beduleva, L., Menshikov, I., Stolyarova, E., Fomina, K., Lobanova, O., Ivanov, P., & Terentiev, A. (2015). Rheumatoid factor in idiotypic regulation of autoimmunity. International Journal of Rheumatic Diseases, 18(4), 408–420. https://doi.org/10.1111/1756-185X.12335
- Beduleva, L., Sidorov, A., Terentiev, A., Varaksin, V., Fomina, K., & Menshikov, I. (2023). Reduction in experimental autoimmune thyroiditis by IgG Fc fragments bearing regRF epitopes. Immunologic Research, 71(1), 83–91. https://doi.org/10.1007/s12026-022-09337-1
- Chemnitz, J. M., Parry, R. V., Nichols, K. E., June, C. H., & Riley, J. L. (2004). SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation. Journal of Immunology, 173(2), 945–954. https://doi.org/10.4049/jimmunol.173.2.945
- Fong, S., Chen, P. P., Crowley, J. J., Silverman, G. J., & Carson, D. A. (1988). Idiotypes and the structural diversity of human rheumatoid factors. Springer Seminars in Immunopathology, 10(2–3), 189–201. https://doi.org/10.1007/BF01857224
- Francisco, L. M., Sage, P. T., & Sharpe, A. H. (2010). The PD-1 pathway in tolerance and autoimmunity. Immunological Reviews, 236(1), 219–242. https://doi.org/10.1111/j.1600-065X.2010.00923.x
- Kunkel, H. G., Agnello, V., Joslin, F. G., Winchester, R. J., & Capra, J. D. (1973). Cross-idiotypic specificity among monoclonal IgM proteins with anti-gammaglobulin activity. The Journal of Experimental Medicine, 137(2), 331–342. https://doi.org/10.1084/jem.137.2.331
- Pauken, K. E., Torchia, J. A., Chaudhri, A., Sharpe, A. H., & Freeman, G. J. (2021). Emerging concepts in PD-1 checkpoint biology. Seminars in Immunology, 52, 101480. https://doi.org/10.1016/j.smim.2021.101480
- Riley, J. L. (2009). PD-1 signaling in primary T cells. Immunological Reviews, 229(1), 114–125. https://doi.org/10.1111/j.1600-065X.2009.00767.x
- Sharpe, A. H., & Pauken, K. E. (2018). The diverse functions of the PD1 inhibitory pathway. Nature Reviews Immunology, 18(3), 153–167. https://doi.org/10.1038/nri.2017.108
- Sidorov, A., Beduleva, L., Menshikov, I., Terentiev, A., & Cherepanov, I. (2020). Physicochemical characteristics of human IgG Fc fragments that expose regulatory rheumatoid factor neoepitopes and may show promise as antirheumatic agents. Biotechnology and Applied Biochemistry, 67(2), 287–293. https://doi.org/10.1002/bab.1849
- Sidorov, A., Beduleva, L., Menshikov, I., Terentiev, A., Stolyarova, E., & Abisheva, N. (2017). Fc fragments of immunoglobulin G are an inductor of regulatory rheumatoid factor and a promising therapeutic agent for rheumatic diseases. International Journal of Biological Macromolecules, 95, 938–945. https://doi.org/10.1016/j.ijbiomac.2016.10.081
- Stolyarova, E., Beduleva, L., Menshikov, I., Snigiryev, A., & Khramova, T. (2018). Mechanism by which regulatory rheumatoid factor prevents experimental autoimmune encephalomyelitis. Endocrine, Metabolic & Immune Disorders - Drug Targets, 18(6), 596–601. https://doi.org/10.2174/1871530318666180308123350
- Thaventhiran, T., Alhumeed, N., Yeang, H. X. A., Sethu, S., Downey, J. S., Alghanem, A. F., Olayanju, A., Smith, E. L., Cross, M. J., Webb, S. D., Williams, D. P., Bristow, A., Ball, C., Stebbings, R., & Sathish, J. G. (2014). Failure to upregulate cell surface PD-1 is associated with dysregulated stimulation of T cells by TGN1412-like CD28 superagonist. Monoclonal Antibodies, 6(5), 1290–1299. https://doi.org/10.4161/mabs.29758
- Yamazaki, T., Akiba, H., Iwai, H., Matsuda, H., Aoki, M., Tanno, Y., Shin, T., Tsuchiya, H., Pardoll, D. M., Okumura, K., Azuma, M., & Yagita, H. (2002). Expression of programmed death 1 ligands by murine T cells and APC. Journal of Immunology, 160(10), 5538–5545. https://doi.org/10.4049/jimmunol.169.10.5538
- Zhang, S., Wang, L., Li, M., Zhang, F., & Zeng, X. (2021). The PD-1/PD-L pathway in rheumatic diseases. Journal of the Formosan Medical Association, 120(1Pt1), 48–59. https://doi.org/10.1016/j.jfma.2020.04.004